[pending] Casely Recalls Wireless Portable Power Banks Due to Fire and Burn Hazards
Pending LLM rewrite. Source: CPSC 25227.
- Product
- Casely Wireless Portable Power Banks
- Category
- Consumer Product
- Distribution
- Distributed nationwide
State
20,084 recalls have nationwide distribution and so reach New Jersey. 0 additional recalls listed New Jersey specifically in their distribution scope.
Most US product recalls have nationwide distribution — the manufacturer ships into every state and the recall sweeps the same way. We include those in this listing because they affect New Jersey consumers even though the source notice doesn’t name the state. State-specific recalls are usually for products with regional distribution (a regional dairy, a local store brand) or where the agency was able to narrow the affected shipments to specific destinations.
If you’re checking whether a recall affects your purchase, the recall detail page lists the exact production lot codes, UPCs, and best-by dates. Match those against your package — distribution scope is a starting filter, not the final answer.
Pending LLM rewrite. Source: CPSC 25227.
Pending LLM rewrite. Source: CPSC 25226.
Pending LLM rewrite. Source: CPSC 25228.
Pending LLM rewrite. Source: CPSC 25230.
Pending LLM rewrite. Source: CPSC 25229.
Glenmark Pharmaceuticals is recalling Lacosamide 150mg tablets nationwide due to manufacturing quality deviations. Consumers should contact their pharmacy or healthcare provider regarding their supply.
Pending LLM rewrite. Source: FDA_DRUG D-0361-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0353-2025.
Pending LLM rewrite. Source: FDA_DEVICE Z-1551-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0324-2025.
Pending LLM rewrite. Source: FDA_FOOD F-0698-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0336-2025.
Pending LLM rewrite. Source: FDA_FOOD F-0701-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0340-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0360-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0337-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0357-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0333-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0331-2025.
Pending LLM rewrite. Source: FDA_DEVICE Z-1546-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0311-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0351-2025.
Pending LLM rewrite. Source: FDA_FOOD F-0702-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0319-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0359-2025.